Seoul National University Hospital
Seoul, 07061, South Korea
NCT Number: NCT03740620
In this study, the subjects are divided into two groups (group I: intervention group = the nasotracheal tube inserted with the bevel of the nasal tube facing the direction of the patient's head, and Group II: conventional group = the bevel of the tube toward the left side of the subject). After the endotracheal tube is introduced, a flexible endoscope is used to evaluate whether the tube is located below the inferior turbinate, i.e. in the lower pathway.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seoul, 07061, South Korea
Primary outcome
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The bevel of the nasotracheal tube facing cephalad direction of the patient
The bevel of the nasotracheal tube facing the left side of the patient
Time frame: right after completion of the intubation
incidence of tracheal tube passing through the lower pathway (beneath the inferior turbinate and immediately above the nasal floor of the nostril)
Time frame: from the start of the intubation to the completion of the intubation, which is confirmed by the appearance of end-tidal CO2 curve, up to 60 seconds
time to complete endotracheal intubation
Time frame: right after completion of the intubation
incidence and severity of epistaxis
Seoul National University Hospital
Other
The Effect of Bevel Direction on the Pathway of the Tracheal Tube in the Nasal Cavity During Nasotracheal Intubation: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269849
Cardiovascular Abnormalities, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT06985108
Epistaxis, Hemorrhage
Diyarbakır, Turkey (Türkiye)
View Trial DetailsNCT06906861
Epistaxis, Hemorrhage
Kathmandu, Bagmati, Nepal
View Trial DetailsNCT02517294
Epistaxis, Hemorrhage
Jacksonville, Florida, United States
View Trial Details